Natural history of acute hepatitis C

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue SUPPL. MAY, 2000, Pages

  Tanaka, Eiji ^a   Kiyosawa, Kendo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ACUTE HEPATITIS; ADULT; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NUCLEOTIDE SEQUENCE; PERSISTENT INFECTION; PRIORITY JOURNAL; VIREMIA; VIRUS GENOME; VIRUS PATHOGENESIS;

EID: 0033944608     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02112.x     Document Type: Conference Paper

References (25)

1. Alter HJ, Purcell RH, Shih JW et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N. Engl. J. Med. 1989; 321: 1494-500.
2. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-5.
3. Aach RD, Stevens CE, Hollinger FB et al. Hepatitis C virus infection in post-transfusion hepatitis: an analysis with first- and second-generation assays. N. Engl. J. Med. 1991; 325: 1325-9.
4. Wang JT, Wang TH, Sheu JC et al. Posttransfusion hepatitis revisited by hepatitis C antibody assays and polymerase chain reaction. Gastroenterology 1993; 103: 609-16.
5. Tremolada F, Casarin C, Alberti A et al. Long-term follow-up of non-A, non-B (type C) posttransfusion hepatitis. J. Hepatol. 1992; 16: 273-81.
6. Alter MJ, Margolis HS, Krawczynski K et al. The natural history of community-acquired hepatitis C in the United States. N. Engl. J. Med. 1992; 327: 1899-905.
7. Liang TJ, Jeffers L, Reddy RK et al. Fulminant or subfulminant non-A, non-B viral hepatitis: The role of hepatitis C and E viruses. Gastroenterology 1993; 104: 556-62.
8. Choo QL, Kuo G, Ralston R et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl Acad. Sci. USA 1994; 91: 1294-8.
9. Yuki N, Hayashi N, Kasahara A et al. Quantative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection. Hepatology 1996; 23: 947-52.
10. Kobayashi M, Tanaka E, Matsumoto A et al. Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C. J. Gastroenterol. Hepatol. 1997; 12: 73-6.
11. Yamaguchi K, Tanaka E, Higashi K et al. Adaptation of hepatitis C for persistent infection in patients with acute hepatitis. Gastroenterology 1994; 106: 1344-8.
12. Quiroga JA, Campillo ML, Catillo I et al. IgM antibody to hepatitis C virus in acute and chronic hepatitis C. Hepatology 1991; 14: 38-43.
13. Kato N, Ootsuyama Y, Tanaka T et al. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res. 1992; 22: 107-23.
14. Weiner AJ, Geysen HM, Christopherson C et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proc. Natl Acad. Sci. USA 1992; 89: 3468-72.
15. Koziel MJ, Dudley D, Wong JT et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 1992; 149: 3339-44.
16. Shimizu YK, Hijikata M, Iwamoto A et al. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 1994; 68: 1494-500.
17. Tong MJ, El-Farra NS, Reikes AR et al. Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 1995; 332: 1463-6.
18. Takahashi M, Yamada G, Miyamoto R et al. Natural course of chronic hepatitis C. Am. J. Gastroenterol. 1993; 88: 240-3.
19. Tanaka E, Kiyosawa K, Matsushima T et al. Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: A multi-institution analysis. J. Gastroenterol. Hepatol. 1995: 538-45.
20. Seeff LB, Buskell-Bales Z, Wright EC et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N. Engl. J Med. 1992; 327: 1906-11.
21. Kenny-Walsh E, for the Irish Hepatology Research Group. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N. Engl. J. Med. 1999; 340: 1228-33.
22. Poynard T, Bedossa P, Opolon P et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-32.
23. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis. Hepatology 1994; 20: 15-20.
24. Kage M, Shimamatu K, Nakashima E et al. Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology 1997; 25: 1028-31.
25. Omata M, Yokosuka O, Takano S et al. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 1991; 338: 914-15.